Literature DB >> 17560771

Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.

Ingvild Agledahl1, Paal-André Skjaerpe, John-Bjarne Hansen, Johan Svartberg.   

Abstract

OBJECTIVE: To study the relationships between endogenous testosterone, sex hormone-binding globulin (SHBG) and serum lipids in non-fasting men.
METHODS: We performed a cross-sectional study in 1274 men without known cardiovascular disease who participated in a population-based study, the 1994/1995 Tromsø study. Anthropometric characteristics were measured and questionnaires regarding lifestyle and medical history were completed. Non-fasting blood samples were drawn between 08.00 and 16.00h, and total testosterone, SHBG, triglycerides (TG), total cholesterol (TC) and high-density lipoprotein (HDL) were analyzed.
RESULTS: In stratified analyses based on sampling time, a linear increase in serum TG levels was found in men with total testosterone levels below the 50th percentile during the day (p for trend=0.004). In contrast, serum triglycerides did not change during the day in men with testosterone levels above the 50th percentile. In regression analyses, total testosterone and SHBG were inversely and independently associated with TG (p<0.001 and p<0.001 respectively), and positively and independently associated with HDL (p=0.005 and p<0.001, respectively). Men with an unfavorable lipid profile (HDL <0.90 and TG >1.8) had significantly lower levels of total testosterone and SHBG (p=0.004 and p<0.001, respectively) in age and BMI adjusted analyses, compared to men with a normal lipid profile.
CONCLUSIONS: Low serum total testosterone was associated with a linear increase in serum TG during the day, and was independently associated with an unfavorable lipid profile. Our findings may indicate that low total testosterone is associated with impaired TG metabolism in men.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560771     DOI: 10.1016/j.numecd.2007.01.014

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  16 in total

1.  Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study.

Authors:  T Vikan; S H Johnsen; H Schirmer; I Njølstad; J Svartberg
Journal:  Eur J Epidemiol       Date:  2009-03-05       Impact factor: 8.082

Review 2.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

Review 3.  Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.

Authors:  Patricia Hernandez; Neena Passi; Taher Modarressi; Vivek Kulkarni; Meshal Soni; Fran Burke; Archna Bajaj; Daniel Soffer
Journal:  Curr Atheroscler Rep       Date:  2021-09-13       Impact factor: 5.113

4.  Sex steroids affect triglyceride handling, glucose-dependent insulinotropic polypeptide, and insulin sensitivity: a 1-week randomized clinical trial in healthy young men.

Authors:  Bruno Lapauw; Margriet Ouwens; Leen M 't Hart; Birgitte Wuyts; Jens J Holst; Guy T'Sjoen; Jean-Marc Kaufman; Johannes B Ruige
Journal:  Diabetes Care       Date:  2010-05-18       Impact factor: 19.112

5.  An update on testosterone, HDL and cardiovascular risk in men.

Authors:  Arthi Thirumalai; Katya B Rubinow; Stephanie T Page
Journal:  Clin Lipidol       Date:  2015

6.  Patient satisfaction with testosterone replacement therapies: the reasons behind the choices.

Authors:  Jason R Kovac; Saneal Rajanahally; Ryan P Smith; Robert M Coward; Dolores J Lamb; Larry I Lipshultz
Journal:  J Sex Med       Date:  2013-11-06       Impact factor: 3.802

Review 7.  Vascular Pathways of Testosterone: Clinical Implications.

Authors:  Margarida Lorigo; Melissa Mariana; Nelson Oliveira; Manuel C Lemos; Elisa Cairrao
Journal:  J Cardiovasc Transl Res       Date:  2019-12-09       Impact factor: 4.132

Review 8.  Onset of effects of testosterone treatment and time span until maximum effects are achieved.

Authors:  Farid Saad; Antonio Aversa; Andrea M Isidori; Livia Zafalon; Michael Zitzmann; Louis Gooren
Journal:  Eur J Endocrinol       Date:  2011-07-13       Impact factor: 6.664

9.  Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study.

Authors:  A M Traish; A Haider; G Doros; F Saad
Journal:  Int J Clin Pract       Date:  2013-10-15       Impact factor: 2.503

Review 10.  Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.

Authors:  Peyman Mesbah Oskui; William J French; Michael J Herring; Guy S Mayeda; Steven Burstein; Robert A Kloner
Journal:  J Am Heart Assoc       Date:  2013-11-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.